FR1634M - New sulfonamide that can be used in therapy, in particular for the treatment of various hepatopathies. - Google Patents

New sulfonamide that can be used in therapy, in particular for the treatment of various hepatopathies.

Info

Publication number
FR1634M
FR1634M FR880595A FR880595A FR1634M FR 1634 M FR1634 M FR 1634M FR 880595 A FR880595 A FR 880595A FR 880595 A FR880595 A FR 880595A FR 1634 M FR1634 M FR 1634M
Authority
FR
France
Prior art keywords
hepatopathies
therapy
treatment
various
new sulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR880595A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR880595A priority Critical patent/FR1634M/en
Application granted granted Critical
Publication of FR1634M publication Critical patent/FR1634M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR880595A 1960-09-13 1961-12-01 New sulfonamide that can be used in therapy, in particular for the treatment of various hepatopathies. Active FR1634M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR880595A FR1634M (en) 1960-09-13 1961-12-01 New sulfonamide that can be used in therapy, in particular for the treatment of various hepatopathies.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1034260A CH399471A (en) 1960-09-13 1960-09-13 Process for the preparation of a new sulfonamide
FR872224 1961-09-04
FR880595A FR1634M (en) 1960-09-13 1961-12-01 New sulfonamide that can be used in therapy, in particular for the treatment of various hepatopathies.

Publications (1)

Publication Number Publication Date
FR1634M true FR1634M (en) 1963-01-02

Family

ID=4362172

Family Applications (1)

Application Number Title Priority Date Filing Date
FR880595A Active FR1634M (en) 1960-09-13 1961-12-01 New sulfonamide that can be used in therapy, in particular for the treatment of various hepatopathies.

Country Status (3)

Country Link
CH (1) CH399471A (en)
FR (1) FR1634M (en)
GB (1) GB922049A (en)

Also Published As

Publication number Publication date
CH399471A (en) 1965-09-30
GB922049A (en) 1963-03-27

Similar Documents

Publication Publication Date Title
FR3639M (en) New protein which can be used in therapy, in particular as an agent for the treatment of solid tumors.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR1634M (en) New sulfonamide that can be used in therapy, in particular for the treatment of various hepatopathies.
FR1878M (en) New polysaccharide, usable in therapy, in particular for the treatment of solid tumors.
FR2019M (en) New thioether which can be used in therapy, in particular for the treatment of various solid tumors.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR1903M (en) New medicament based on an ether which can be used, in particular for the treatment of various solid tumors.
FR1898M (en) New substance usable in therapy.
FR2692M (en) New a-nor-b-homo-steroids which can be used in therapy, in particular as anti-inflammatory agents.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR2510M (en) New medicament usable for the treatment of staphylococcal infections and the like.
FR1731M (en) New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.
FR2209M (en) New ether which can be used in therapy, in particular for the treatment of various solid tumors.
FR2323M (en) New drug, in particular for the treatment of follicle-stimulating hyperactivity.
FR3881M (en) Medicament useful in particular for the treatment of tuberculosis.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR1856M (en) New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.
FR2656M (en) New drug, in particular for the treatment of chronic or postprandial hyperlipemia.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.
FR3731M (en) New sulfonamides which can be used in therapy, in particular as chemotherapeutic agents.
FR2744M (en) New sulfonamides which can be used in therapy, in particular as chemotherapeutic agents.
FR2148M (en) Topical composition for the treatment of warts.